Investors are likely to keep an eye on the following small-cap stocks listed on the Australian Securities Exchange.
Noxopharm (ASX:NOX)
Noxopharm passed its final in vivo preclinical safety study for its SOF-SKN drug candidate for autoimmune diseases, with no issues identified, ahead of regulatory submission for the Heracles clinical trial.
Great Western Exploration (ASX:GTE)
Great Western Exploration completed its maiden drilling program at the Sumo niobium target, located within its Yerrida North project in Western Australia.
Swift Networks Group (ASX:SW1)
Swift Networks Group extended the closing date of its entitlement offer by two weeks to May 6, following "significant" global stock market volatility and shareholder requests. The extension allows additional time to receive the entitlement offer material and evaluate the opportunity.
Rincon Resources (ASX:RCR)
Rincon Resources completed a site visit to its Laverton gold project in Western Australia and is now preparing for its first drilling on-ground since 2021.
Aurumin (ASX:AUN)
Aurumin completed reverse circulation drilling at its Johnson Range project, part of the Sandstone gold project in Western Australia. Samples have been finalized and are being transported to the laboratory, with results expected in May.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。